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ABSTRACT
Objectives: The objective was to determine the
frequency of trachoma genotypes of Chlamydia
trachomatis-positive urogenital tract (UGT) specimens
from remote areas of the Australian Northern Territory
(NT).
Setting: The setting was analysis of remnants of
C. trachomatis positive primarily UGT specimens
obtained in the course of clinical practice. The
specimens were obtained from two pathology service
providers.
Participants: From 3356 C. trachomatis specimens
collected during May 2012–April 2013, 439 were
selected for genotyping, with a focus on specimens
from postpubescent patients, in remote Aboriginal
communities where ocular trachoma is potentially
present.
Primary and secondary outcome measures:
The primary outcome measure was the proportion of
successfully genotyped UGT specimens that were
trachoma genotypes. The secondary outcome
measures were the distribution of genotypes, and the
frequencies of different classes of specimens able to
be genotyped.
Results: Zero of 217 successfully genotyped UGT
specimens yielded trachoma genotypes (95% CI
for frequency=0–0.017). For UGT specimens, the
genotypes were E (41%), F (22%), D (21%) and K
(7%), with J, H and G and mixed genotypes each at
1–4%. Four of the five genotyped eye swabs yielded
trachoma genotype Ba, and the other genotype J.
Two hundred twenty-two specimens (50.6%) were
successfully genotyped. Urine specimens were less
likely to be typable than vaginal swabs (p<0.0001).
Conclusions: Unlike in some other studies, in the
remote NT, trachoma genotypes of C. trachomatis were
not found circulating in UGT specimens from 2012 to
2013. Therefore, C. trachomatis genotypes in UGT
specimens from young children can be informative as
to whether the organism has been acquired through
sexual contact. We suggest inclusion of C. trachomatis
genotyping in guidelines examining the source of
sexually transmitted infections in young children in
areas where trachoma genotypes may continue to
circulate, and continued surveillance of UGT
C. trachomatis genotypes.
INTRODUCTION
Chlamydia trachomatis causes ocular infections
and sexually transmitted infections (STI) of
the urogenital tract (UGT) in humans.
Trachoma is a potentially blinding class of
C. trachomatis disease with a characteristic
pathology encompassing repeated infections
leading to hypersensitivity, secondary bacter-
ial infection, anatomical changes and conse-
quent corneal scarring.1 The C. trachomatis
strains associated with trachoma are distinct
from other strains, which are primarily asso-
ciated with UGT infections, but are also able
to cause acute conjunctivitis (paratrachoma)
that does not progress to the distinctive
Strengths and limitations of this study
▪ The study is highly targeted to a difficult
problem in child protection, and the context and
potential for translation is considered and dis-
cussed very carefully. Consistent with this, the
authors included appropriate experts with exten-
sive front line clinical and child protection
experience.
▪ It is the largest survey of genotypes of
Chlamydia trachomatis from remote northern
Australia.
▪ The possibility that ocular genotypes were
present in the urogenital specimens but below
the detection level of the genotyping assay
cannot be ruled out.
▪ The failure rate of the genotyping assay meant
that the power of the study was reduced
somewhat.
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pathologies of trachoma. Trachoma is usually transmit-
ted from child to child with ocular secretions, while
paratrachoma is acquired by transmission from UGT
infections, or as a result of mother to child transmission
at delivery.2
The established basis for deﬁning C. trachomatis strains
is variation in the ompA gene, which encodes the immu-
nodominant major outer membrane protein. OmpA gen-
otypes A, B, Ba and C are associated with trachoma,
genotypes D, E, F, G, H, Ia, J and K with non-invasive
UGT infections and paratrachoma, and genotypes L1,
L2, L2b and L3 with less common, invasive, lymphogra-
nuloma venereum infections.2–4 The nomenclature
reﬂects serology-based typing, although direct analysis of
the ompA gene is now universally used.
When C. trachomatis is detected in UGT samples from a
child, potential explanations are sexual abuse, autoinocu-
lation from an ocular source, perinatal mother-to-child
transmission, or contamination of specimens. Our
research group has been investigating potential mechan-
isms leading to STI pathogen detection in UGT speci-
mens, in the absence of sexual contact, in an endeavour
to place numerical boundaries on their probabilities. For
example, we have estimated the probability of the transfer
of environmental STI pathogen-derived nucleic acid to
diagnostic specimens.5 We demonstrated that while toilet-
bathroom facilities in some Northern Territory (NT)
primary health clinics were contaminated with nucleic
acid from STI pathogens, the probability of this material
ﬁnding its way into diagnostic specimens was low, but not
zero. Therefore, it was recommended that UGT speci-
mens from young children for STI testing should be
obtained by trained staff in specialised facilities.
The current study addresses the issue of potential
autoinoculation and/or infection of the UGT site with
C. trachomatis derived from ocular C. trachomatis infec-
tion. This is particularly relevant to the remote regions
of northern and Central Australia where trachoma
remains endemic.6 7 Trachoma typically manifests as
repeated childhood infections that are spread by the
transfer of secretions from the eyes, usually in conditions
of crowded living and poor hygiene. There are anec-
dotal reports that such secretions could contaminate the
UGT, thus leading to detection of C. trachomatis in UGT
specimens in the absence of sexual contact. While there
are no published reports that clearly describe ocular to
UGT transmission, or autoinoculation, it is well known
that transmission from the UGT to the ocular site occurs
in the setting of paratrachoma, and there is also evi-
dence for transmission within families that could involve
multiple modes.2 8 9
Our study addresses whether trachoma-associated
ompA C. trachomatis genotypes are found in UGT diag-
nostic specimens from remote regions of the NT. If
trachoma genotypes were very rare or undetectable in
sexual transmission networks in the study area, then a
trachoma genotype in a UGT sample from a young child
would be unlikely to have been acquired from sexual
transmission networks, and this is of potential signiﬁ-
cance in the child protection context.
METHODS
We obtained deidentiﬁed C. trachomatis-positive diagnos-
tic specimens that originated from the NT of Australia,
and were collected between April 2012 and April 2013.
Two pathology service providers, who at the time of this
study accounted for the great majority of STI diagnostic
testing in the NT, provided the specimens. Western
Diagnostics Pathology (WDP) used the Aptima C. tracho-
matis diagnostic system (Hologic (Australia) Pty Ltd,
Macquarie Park, New South Wales), and provided
primary clinical samples as swabs and/or urine in the
Aptima transport medium that had been prepared in
accordance with the manufacturers of the Aptima
system. The Royal Darwin Hospital (RDH) used the
Siemens Versant C. trachomatis diagnostic system
(Siemens Healthcare Australia, Bayswater, Victoria), and
provided us with remnant puriﬁed total nucleic acid
from clinical specimens. We contracted RDH to extract
total nucleic acid from the Aptima swabs and urine spe-
cimens from WDP, using the extraction module of the
Siemens Versant instrument, according to the manufac-
turer’s instructions. The specimens were stored at 4°C
for a period of up to 6 months, then at −80°C. Puriﬁed
nucleic acid was stored at −80°C.
Our objective was to analyse specimens from remote
indigenous communities. The great majority of such
specimens were from WDP. Accordingly, we selected
434 specimens from the 2229 specimens available from
WDP. These constituted 47% of the specimens from
remote indigenous communities. They were selected
on the basis of representing the geographical diversity
and specimen type of the total collection. The speci-
mens were classiﬁed as originating either from the Top
End (260 specimens), or Central Australia (174 speci-
mens) (ﬁgure 1). All the specimens were of UGT
origin, except four eye swabs from the inland regions
of the Top End. To this collection, we added three
additional eye swabs from the inland regions of the
Top End, and two UGT specimens from Central
Australia from RDH, to yield a total of 439 specimens
(263, Top End and 176, central Australia). This
number was judged as sufﬁcient to generate usefully
narrow boundaries on the CI for the frequency of
trachoma genotypes. The UGT specimens were primar-
ily urine (75.4% of the Top End UGT specimens,
93.8% of central Australia UGT specimens). The other
specimens were mostly lower vaginal swabs (LVS)
(11.7% of Top End UGT specimens and 1.7% of
Central Australia UGT specimens), with the remainder
being other UGT swabs, or thin prep specimens. There
were no rectal specimens. The breakdown of specimen
types selected for analysis was similar to that for the
entire collection from WDP; 70.2% urine specimens,
15.5% LVSs, with the remainder distributed between
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other UGT specimens and eye swabs. The ages were
primarily adolescent and young adults, with only ﬁve
specimens from patients <12 years old; 55.4% of the
specimens were from female patients, 44.6% from male
patients. The corresponding ﬁgures for the Top End
and central specimens were 60.8% female, 39.2% male,
and 47.2% female, 52.8% male, respectively.
Following nucleic acid isolation, each sample was
assessed for DNA quality using a quantitative PCR
(qPCR) for a 260-bp fragment of the human β-globin
gene,10 and specimens failing this step were not analysed
further. The remaining nucleic acid preparations were
analysed for C. trachomatis ompA genotypes using a two-
stage method as described previously.4 This is based on
hydrolysis probes, is performed on a qPCR platform,
and supports the detection of multiple ompA variants in
individual specimens. A limitation is that the closely
related ompA genotypes B and Ba are not discriminated,
so B/Ba genotypes were resolved by sequencing or high-
resolution melting analysis (HRMA) of an ompA internal
fragment ampliﬁed by PCR (see online supplementary
ﬁgures S1 and S2).
Figure 1 The Australian Northern Territory, with the boundary between the ‘Top End’ and ‘Central’ study areas indicated.
Giffard PM, et al. BMJ Open 2016;6:e009624. doi:10.1136/bmjopen-2015-009624 3
Open Access
group.bmj.com on October 19, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Unless otherwise stated, the signiﬁcances of differ-
ences in frequencies were assessed using the two-tailed
Fisher’s exact test.
RESULTS
Genotyping was successful for 222 of the 439 specimens
(50.6%), which included ﬁve of the seven eye swabs. Of
the untypeable specimens, 28% yielded no signal in the
β-globin gene PCR, 52% failed at the ﬁrst stage of
the genotyping, and 20% failed at the second stage of
the genotyping. The LVS specimens were more likely to
be typeable (29/33 (89%)) than urine specimens (165/
358 (46%)) (p<0.0001); urine specimens from female
patients were more likely to be typeable (93/169 (55%))
than those from male patients (72/189 (38%))
(p=0.0015); and male urine specimens from the
Top End were more likely to be typeable (45/97
(46%)) than male urine specimens from Central
Australia (27/92 (29%)) (p=0.0172). A breakdown of
the typeability of different classes of specimens is pro-
vided as online supplementary data. We could ﬁnd no
relationship between length of storage and typeability
(data not shown).
A single ompA genotype was detected in 212 UGT spe-
cimens and all ﬁve typeable eye swabs, and more than
one ompA genotype was detected in ﬁve of the UGT spe-
cimens. Most importantly, no trachoma genotypes were
identiﬁed in the UGT specimens (ﬁgure 2, table 1).
The most common genotypes were D, E and F and K
with genotypes G, H, J also present, but less common.
The differences in the frequencies of genotypes D, E
and F between the Top End and Central Australia were
signiﬁcant (χ2 p<0.0001), indicating that the C. trachoma-
tis populations are not homogeneous across the NT. We
could identify no correlations between genotype and
age or gender (data not shown).
Four of the ﬁve typeable eye swabs were genotype
B/Ba, according to the hydrolysis probe method, while
the other was genotype J. HRMA revealed that all four
B/Ba specimens were genotype Ba. PCR products from
three of the latter specimens were sequenced, conﬁrm-
ing genotype Ba. Three of the genotype Ba swabs were
from prepubescent children, and the fourth was from
an adult in late middle age, while the genotype J eye
swab was from a young adult.
DISCUSSION
Our objective is to inform the clinical and social
response to the detection of C. trachomatis in UGT speci-
mens in young children. Clinical guidelines frequently
state that detection of an STI pathogen in a UGT
sample is strongly indicative of sexual abuse and, even in
the absence of a disclosure of sexual abuse, triggers an
investigation by child protection and/or the justice
system.16–20 This can be a difﬁcult process because it is
unlikely that the positive predictive value of a positive
STI test for sexual contact is known with any accuracy
for a young child, and both false positives and false
negatives can be very problematic. In the NT in 2007,
reports of high levels of child sexual abuse in remote
Indigenous communities21 led to large-scale and conten-
tious social interventions particularly on the part of the
Australian Commonwealth Government. The high
public proﬁle of this issue, the imperatives to protect vul-
nerable members of the community, the remote loca-
tions, and well justiﬁed concerns regarding stereotyping
of Aboriginal individuals, families and communities
make this an exceptionally challenging area for service
delivery.
Figure 2 The abundances of the ompA genotypes, in the
samples obtained from the two study areas. All are UGT
specimens except for the five eye swabs, which represent all
four Top End genotype Ba specimens, and one Top End
genotype J specimen. UGA, urogenital tract.
Table 1 Chlamydia trachomatis genotypes in Australian
studies, including the current study, relevant to remote
regions of Australia, and/or reporting trachoma genotypes
in non-ocular samples
Study
Trachoma
genotypes
in UGT
samples
Trachoma
genotypes
in ocular
samples
This study 0/217 Ba×4
Top End rural/remote,
1986–199111 12
B×21/44 B×54
Ba×13
C×31
Western Australia remote13 N/A Ba×22
C×13
NT remote14 N/A Ba×4
C×27
Rural indigenous15 0/32 N/A
Australian men who have sex
with men15
B×1/39 N/A
N/A, not applicable; UGA, urogenital tract.
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In this study, the largest survey of ompA genotypes of
C. trachomatis from remote Australia, of the 217 UGT
specimens that were successfully genotyped, none
yielded a trachoma genotype. This indicates that strains
with trachoma genotypes are not currently contributing
signiﬁcantly to sexually transmitted C. trachomatis in the
remote NT. The ﬁnding is similar to a previous smaller
survey of C. trachomatis genotypes in UGT specimens in
‘rural’ regions of Australia15 (table 1). By contrast, four
of the ﬁve genotyped eye swabs were trachoma genotype
Ba, indicating that trachoma strains remain extant and
associated with the ocular site.
Our results are relevant to the response when
C. trachomatis is identiﬁed in UGT specimens in young
children in remote regions of Australia, where
trachoma strains of C. trachomatis continue to circulate.
If there is no obvious evidence to account for the pres-
ence of C. trachomatis, such as disclosure of sexual
contact, the strength of evidence for sexual contact is
affected by the probability of autoinoculation of the
UGT, or contamination of the specimen by trachoma
strains of C. trachomatis. Our ﬁndings demonstrate that
where C. trachomatis is identiﬁed in a UGT sample from
a young child, genotyping of the C. trachomatis can be
informative regarding inference of sexual contact or
autoinoculation from an ocular site. The presence of an
UGT genotype would represent stronger evidence of
abuse on the basis of being consistent with acquisition
from adult sexual networks. Conversely, identiﬁcation of
a trachoma genotype would constitute weaker evidence
for acquisition from local adult sexual networks. As a
result, in regions with endemic trachoma, genotyping
should be incorporated into formal guidelines for the
investigation of genital chlamydia in children.
A conservative approach to estimating the highest rea-
sonable proportion of trachoma genotypes in UGT spe-
cimens in the study area is to determine the conﬁdence
limits on a frequency of 0/217. The upper boundary of
the 95% CI is 0.017 (exact binomial method). While this
directly provides insight into the probability that the
C. trachomatis in a UGT sample has arisen from an
ocular site, a more rigorous way to use that value would
be to combine it with trachoma genotype frequencies in
paediatric UGT specimens in the study area. An excess
of trachoma genotypes in UGT specimens from children
compared with UGT specimens from adults would
deﬁne a lower boundary for the proportion of
C. trachomatis-positive UGT specimens in children that
cannot be accounted for by transmission from adult
sexual networks. This, in turn, would enable the calcula-
tion of boundaries for pretest and post-test probabilities
that the C. trachomatis in a paediatric sample arose from
the ocular site.
It would be unwise to assume that the frequency of
trachoma genotypes in adult UGT specimens in the
study area is invariant. There are reports of trachoma
genotypes in UGT specimens,22–28 and also in rectal spe-
cimens.15 Most commonly, if a trachoma genotype is
identiﬁed in a survey of UGT specimens, then it is geno-
type B, and is in <5% of specimens. Most ﬁndings of
genotype B in UGT specimens are from areas in which
trachoma no longer exists, so it is likely that genotype B
C. trachomatis, while usually classed as ‘trachoma’ strain,
can be sexually transmitted in a sustainable manner.
Speciﬁc examples of evidence for transmission of
trachoma genotypes in sexual networks are a survey of
215 C. trachomatis-positive endocervical swab specimens
from Japanese patients, of which one yielded genotype
A, 11 genotype B, two genotype Ba, and one
genotype C.28 Similarly, a survey of 50 urethral swabs and
urine specimens from male patients in Greece yielded
two genotype Bs,26 and similar studies in Finland in 1987
and 1996 yielded two genotype Bs from 51 specimens,
and two genotype Bs from122 specimens, respectively.27
Particularly relevant to our results, and an outlier with
respect to the proportion of UGT specimens containing
trachoma strains, was a serotyping-based study performed
in the remote north of the NT in the 1980s and
1990s.11 12 Forty-eight per cent of C. trachomatis-positive
cervical swabs gave rise to serovar B isolates, while sero-
vars B, Ba and C were identiﬁed in ocular swabs. Serovars
Ba and C were not found in UGT specimens, with the
possible exception of one specimen that also contained a
urogenital serovar (table 1). It is signiﬁcant that those
specimens originated from a geographical area encom-
passed by the current study. Therefore, there is a case for
ongoing surveillance of genotypes of C. trachomatis in the
study area, with the objective of continually reﬁning
numerical boundaries for the frequencies of trachoma
genotypes in adult and paediatric UGT specimens.
While the critical result in this current study is the
lack of trachoma genotypes in UGT specimens, the
results from the eye swabs are of interest and add to
the understanding of the diversity of the C. trachomatis in
the remote NT. Four of the ﬁve ocular specimens were
genotype Ba. This is consistent with two previous studies
of ocular C. trachomatis in remote Australia, which
detected genotypes Ba and C,13 14 and the serotyping-
based study described above in which serovars B, Ba and
C were found in eye swabs11 12(table 1). The ages of the
patients giving rise to the genotype Ba eye swabs are con-
sistent with the association of this genotype and trach-
oma, while the age of the patient giving rise to the
genotype J eye isolate is consistent with paratrachoma.
The proportion of specimens that were able to be suc-
cessfully genotyped was lower than in another study
using this assay.4 The reason is not fully understood. A
contributing factor may have been that approximately
half the specimens tested by Stevens and coworkers4
were anal swabs, and the other half were urine speci-
mens, while the great majority of the specimens in the
current study were urine. Urine specimens are known to
have lower C. trachomatis loads than UGT swab speci-
mens,29 30 and consistent with this, the LVS swabs in the
current study were much more likely to be typeable than
urine specimens. The lower typeability of urine from
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male patients compared with female patients, and for
male urine from Central Australia compared with the
Top End, remains unexplained. The storage of speci-
mens in Aptima transport medium may have affected
typeability. However, it has previously been shown that
such storage does not preclude downstream genotyp-
ing,31 and in our study, the lack of correlation between
time of storage at 4°C and typeability suggests that the
RNA was not progressively degraded.
We considered whether the genotyping failure rate
could bias the results. It is possible that speciﬁc instances
of transfer to the UGT of C. trachomatis from an ocular
source could result in very low levels of C. trachomatis in
a corresponding UGT specimen and, therefore, com-
promise genotyping. However, our primary objective was
to determine the genotypes circulating in the conven-
tional sexual networks, rather than identiﬁcation of spe-
ciﬁc instances of transfer of trachoma genotypes to the
UGT. We cannot exclude the notion that trachoma gen-
otypes are circulating in the sexual transmission net-
works, but never reaching the threshold for successful
genotyping. However, we know of no reports that would
support such a scenario. Therefore, we regard our study
as credible in indicating which genotypes are circulating
as STI pathogens in the study area, but with a potential
limitation regarding the detection of speciﬁc instances
of transfer to the UGT of C. trachomatis arising from
ocular infections. It is likely that reliable genotyping of
C. trachomatis in paediatric specimens in the context of
child protection investigations will require careful
sample collection, handling and transport for this very
sensitive genotyping methodology, as has previously
been suggested.5
In conclusion, we could not detect trachoma geno-
types circulating in sexual transmission networks in the
remote NT. Genotyping of C. trachomatis identiﬁed in
UGT specimens from young children can, therefore, be
informative in the context of child protection investiga-
tions. Trachoma genotypes should not be considered
equivalent to UGT genotypes, and we suggest that inclu-
sion of genotyping should be considered in guidelines
and policies specifying institutional responses to STI
diagnosis in young children in regions where ocular
infections with trachoma strains may continue to exist. It
is important that historical data from the study area and
other studies worldwide, indicate that trachoma geno-
types and, in particular, genotype B, can be transmitted
through sexual networks, although is usually very
uncommon if present at all. This suggests that ongoing
genotyping of C. trachomatis in UGT diagnostic speci-
mens could be of considerable value.
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